Compugen Ltd.
A clinical-stage company developing cancer immunotherapies using an AI platform.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
Description
Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-02-28 15:14 |
Form 20-F for 2021
|
English | 2.0 MB | ||
| 2022-02-28 15:14 |
Form 20-F for 2021
|
English | 36.0 KB | ||
| 2022-02-24 14:59 |
Reports Fourth Quarter and Full Year 2021 Results
|
English | 93.3 KB | ||
| 2022-02-24 14:59 |
Reports Fourth Quarter and Full Year 2021 Results
|
English | 36.1 KB | ||
| 2022-02-14 17:59 |
Schedule 13G/A filed by Nikko Asset Management Americas, Inc.
|
English | 313.0 KB | ||
| 2022-02-14 17:59 |
Schedule 13G/A filed by Nikko Asset Management Americas, Inc.
|
English | 35.9 KB | ||
| 2022-02-10 14:59 |
Compugen to Release Fourth Quarter and Full Year 2021 Results on Thursday, Febr…
|
English | 82.9 KB | ||
| 2022-02-10 14:59 |
Compugen to Release Fourth Quarter and Full Year 2021 Results on Thursday, Febr…
|
English | 36.0 KB | ||
| 2022-02-10 10:31 |
Schedule 13G/A filed by ARK Investment Management LLC
|
English | 236.0 KB | ||
| 2022-02-10 10:31 |
Schedule 13G/A filed by ARK Investment Management LLC
|
English | 35.8 KB | ||
| 2022-02-09 14:59 |
to Present at the 11th Annual SVB Leerink Global
Healthcare Conference
|
English | 84.8 KB | ||
| 2022-02-09 14:59 |
to Present at the 11th Annual SVB Leerink Global
Healthcare Conference
|
English | 35.9 KB | ||
| 2022-02-06 16:29 |
SCHEDULE 13G/A-Nikko Asset Management
|
English | 140.3 KB | ||
| 2022-02-06 16:29 |
SCHEDULE 13G/A-Nikko Asset Management
|
English | 35.9 KB | ||
| 2022-01-18 14:59 |
Expands COM701 Intellectual Property Portfolio with New U.S. Patent Covering Tr…
|
English | 101.4 KB |
Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compugen Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compugen Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
